Grant recipient
Trans Tasman Radiation Oncology Group Limited
$8.1m
whole-of-term value of 3 grant awards published 2026-02-23 to 2026-08-31
$1.3m falls in 2026-27, from 3 active awards. estimate: annualised
Award values as published on GrantConnect, each over the grant’s whole term. GrantConnect publishes no ABN, so awards are grouped by name: spellings that differ only in case, punctuation or a company suffix count as one recipient. How recipients are grouped
By agency
| Granting agency | Awards | Total value |
|---|---|---|
| Department of Health, Disability and Ageing | 2 | $4.2m |
| National Health and Medical Research Council (NHMRC) | 1 | $3.9m |
Awards
Largest first.
| Activity | Agency | Category | Round | Published | Term | Value |
|---|---|---|---|---|---|---|
| Moderately Hypofractionated versus Conventional Chemoradiation with Co… GA578192 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7814 | 2026-08-31 | 2026-10-01 to 2031-09-30 | $3.9m |
| Phase 3 trial testing the safety and effectiveness of delivering simul… GA537866 |
Department of Health, Disability and Ageing | Medical Research | GO7555 | 2026-02-23 | 2026-03-01 to 2033-02-28 | $3.1m |
| A randomized Phase 3 trial comparing stereotactic body radiotherapy (S… GA565448 |
Department of Health, Disability and Ageing | Medical Research | GO7555 | 2026-06-22 | 2026-06-01 to 2030-05-31 | $1.1m |
These records are as published by the agencies on GrantConnect, where each award can be found by its ID. If something here is wrong, the agency that published the award can correct it, and we will pick up the correction at the next load. Report a problem with this page.